| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
|
Cancer Cell
|
2007
|
3.14
|
|
2
|
Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.
|
Eur Urol
|
2011
|
2.90
|
|
3
|
P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
|
Clin Cancer Res
|
2007
|
1.74
|
|
4
|
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals.
|
Biotechniques
|
2007
|
1.66
|
|
5
|
Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
|
J Nucl Med
|
2012
|
1.53
|
|
6
|
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.
|
Mol Cancer Ther
|
2008
|
1.36
|
|
7
|
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer.
|
Ann Surg Oncol
|
2011
|
1.25
|
|
8
|
Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
|
Cancer Res
|
2002
|
1.21
|
|
9
|
Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model.
|
J Biomed Opt
|
2011
|
1.16
|
|
10
|
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib.
|
Invest New Drugs
|
2008
|
1.10
|
|
11
|
Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP.
|
Invest New Drugs
|
2010
|
1.09
|
|
12
|
Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
|
Eur Urol
|
2012
|
1.09
|
|
13
|
Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.
|
Bioconjug Chem
|
2011
|
0.99
|
|
14
|
Imaging agents for the chemokine receptor 4 (CXCR4).
|
Chem Soc Rev
|
2012
|
0.98
|
|
15
|
Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
|
Clin Cancer Res
|
2010
|
0.93
|
|
16
|
Image navigation as a means to expand the boundaries of fluorescence-guided surgery.
|
Phys Med Biol
|
2012
|
0.91
|
|
17
|
Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.
|
Mol Pharm
|
2011
|
0.90
|
|
18
|
Targeted non-covalent self-assembled nanoparticles based on human serum albumin.
|
Biomaterials
|
2011
|
0.88
|
|
19
|
Dual-emissive quantum dots for multispectral intraoperative fluorescence imaging.
|
Biomaterials
|
2010
|
0.86
|
|
20
|
Multispectral visualization of surgical safety-margins using fluorescent marker seeds.
|
Am J Nucl Med Mol Imaging
|
2012
|
0.85
|
|
21
|
Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer.
|
Appl Radiat Isot
|
2010
|
0.84
|
|
22
|
Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.
|
Transl Oncol
|
2011
|
0.84
|
|
23
|
Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography.
|
Biomed Chromatogr
|
2007
|
0.83
|
|
24
|
Phosphorescence imaging of living cells with amino acid-functionalized tris(2-phenylpyridine)iridium(III) complexes.
|
Inorg Chem
|
2012
|
0.83
|
|
25
|
Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.
|
Chembiochem
|
2012
|
0.83
|
|
26
|
Development of a Hybrid Tracer for SPECT and Optical Imaging of Bacterial Infections.
|
Bioconjug Chem
|
2015
|
0.82
|
|
27
|
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung.
|
Clin Exp Metastasis
|
2008
|
0.82
|
|
28
|
Potential value of color-coded dynamic breast-specific gamma-imaging; comparing (99m)Tc-(V)-DMSA, (99m)Tc-MIBI, and (99m)Tc-HDP in a mouse mammary tumor model.
|
Appl Radiat Isot
|
2010
|
0.80
|
|
29
|
Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype.
|
Invest New Drugs
|
2007
|
0.79
|
|
30
|
An activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime.
|
Chem Commun (Camb)
|
2014
|
0.77
|
|
31
|
Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.77
|
|
32
|
Cannulation of the jugular vein in mice.
|
Lab Anim
|
2005
|
0.75
|
|
33
|
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
|
Cancer Chemother Pharmacol
|
2005
|
0.75
|